• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.行动呼吁:如何改善患者报告结局的使用以指导类风湿关节炎的临床决策。
Rheumatol Int. 2018 Jun;38(6):935-947. doi: 10.1007/s00296-018-4005-5. Epub 2018 Mar 21.
2
Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes.患者对实现达标治疗目标的看法:对患者报告结局的批判性审视。
Arthritis Care Res (Hoboken). 2013 Oct;65(10):1707-12. doi: 10.1002/acr.22048.
3
Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation.在类风湿关节炎随机对照试验中使用每日电子患者报告结局(PRO)日记:基本原理与实施
Trials. 2019 Mar 22;20(1):182. doi: 10.1186/s13063-019-3272-0.
4
"Am I OK?" using human centered design to empower rheumatoid arthritis patients through patient reported outcomes.“我还好吗?”——通过患者报告结局,以人本主义设计赋能类风湿关节炎患者。
Patient Educ Couns. 2019 Mar;102(3):503-510. doi: 10.1016/j.pec.2018.10.016. Epub 2018 Oct 28.
5
Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study.目标治疗类风湿关节炎:使用患者意见实时匿名联络系统评估患者观点:RA T2T PORTAL 研究。
Int J Rheum Dis. 2019 May;22(5):874-879. doi: 10.1111/1756-185X.13514. Epub 2019 Feb 22.
6
Patient-reported outcomes in RA care improve patient communication, decision-making, satisfaction and confidence: qualitative results.类风湿关节炎护理中的患者报告结局可改善患者沟通、决策、满意度和信心:定性结果。
Rheumatology (Oxford). 2020 Jul 1;59(7):1662-1670. doi: 10.1093/rheumatology/kez506.
7
Patient-driven outcomes in rheumatoid arthritis.类风湿关节炎中以患者为导向的结局
J Rheumatol Suppl. 2009 Jun;82:33-8. doi: 10.3899/jrheum.090129.
8
Impact of rheumatoid arthritis in Turkey: a questionnaire study.土耳其类风湿关节炎的影响:一项问卷调查研究。
Clin Exp Rheumatol. 2014 Jul-Aug;32(4):477-83. Epub 2014 Jun 6.
9
Suppressing Inflammation in Rheumatoid Arthritis: Does Patient Global Assessment Blur the Target? A Practice-Based Call for a Paradigm Change.抑制类风湿关节炎炎症:患者整体评估是否模糊了目标?基于实践的范式转变呼吁。
Arthritis Care Res (Hoboken). 2018 Mar;70(3):369-378. doi: 10.1002/acr.23284. Epub 2018 Jan 30.
10
Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.群组认知行为方案对减轻类风湿关节炎疲劳的影响:RAFT RCT 伴有经济和定性评估。
Health Technol Assess. 2019 Oct;23(57):1-130. doi: 10.3310/hta23570.

引用本文的文献

1
Case Report: Endocrine, immune and disease dynamics in a patient with rheumatoid arthritis during flare and medication change.病例报告:类风湿关节炎患者病情发作及药物变更期间的内分泌、免疫和疾病动态
Front Immunol. 2025 May 8;16:1491475. doi: 10.3389/fimmu.2025.1491475. eCollection 2025.
2
Improving Clinical Management and Patient-Reported Outcomes Among Patients with Rheumatoid Arthritis in China via Real-world Evidence (IMPROVE Study): A Multicenter Prospective Cohort Study.通过真实世界证据改善中国类风湿性关节炎患者的临床管理和患者报告结局(IMPROVE研究):一项多中心前瞻性队列研究
Adv Ther. 2025 Jun;42(6):2906-2921. doi: 10.1007/s12325-025-03179-7. Epub 2025 Apr 29.
3
Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: Rasch measurement theory to identify items and domains.类风湿关节炎疾病活动度的患者报告结局测量:运用拉施测量理论确定条目和领域。
Rheumatology (Oxford). 2025 Sep 1;64(9):4902-4912. doi: 10.1093/rheumatology/keaf189.
4
Patient perceptions of an electronic-health-record-based rheumatoid arthritis outcomes dashboard: a mixed-methods study.基于电子病历的类风湿关节炎结果数据仪表盘的患者感知:一项混合方法研究。
BMC Med Inform Decis Mak. 2024 Oct 12;24(1):302. doi: 10.1186/s12911-024-02696-9.
5
A Collection of Components to Design Clinical Dashboards Incorporating Patient-Reported Outcome Measures: Qualitative Study.纳入患者报告结局指标的临床仪表盘设计组件集:定性研究
J Med Internet Res. 2024 Oct 2;26:e55267. doi: 10.2196/55267.
6
Classifying Self-Reported Rheumatoid Arthritis Flares Using Daily Patient-Generated Data From a Smartphone App: Exploratory Analysis Applying Machine Learning Approaches.利用智能手机应用程序中患者每日生成的数据对自我报告的类风湿性关节炎发作进行分类:应用机器学习方法的探索性分析
JMIR Form Res. 2024 May 14;8:e50679. doi: 10.2196/50679.
7
Responsiveness and sensitivity of PROMs to change in disease activity status in early and established rheumatoid arthritis.患者报告结局量表(PROMs)对早期和确诊类风湿关节炎疾病活动状态变化的反应性和敏感性。
Rheumatology (Oxford). 2025 Mar 1;64(3):1060-1067. doi: 10.1093/rheumatology/keae213.
8
Remote monitoring of patients with rheumatoid arthritis in a low disease activity state: a mixed methods evaluation across six hospitals in London, UK.英国伦敦六家医院的类风湿关节炎低疾病活动度患者远程监测:混合方法评估。
Rheumatology (Oxford). 2024 Oct 1;63(10):2721-2733. doi: 10.1093/rheumatology/keae112.
9
The perspective of Polish patients with rheumatoid arthritis - treatment expectations, patient-reported outcomes, and digital literacy (the SENSE study).波兰类风湿性关节炎患者的观点——治疗期望、患者报告的结果和数字素养(SENSE研究)
Reumatologia. 2023;61(5):331-338. doi: 10.5114/reum/171625. Epub 2023 Oct 6.
10
Patients with rheumatoid arthritis presenting with mono- or oligo-arthritis and high VAS-ratings remain the most fatigued during 5 years of follow-up.在 5 年的随访中,出现单关节炎或寡关节炎和高 VAS 评分的类风湿关节炎患者仍然是最疲劳的。
Rheumatology (Oxford). 2024 May 3;63(6):1574-1581. doi: 10.1093/rheumatology/kead429.

本文引用的文献

1
Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.使用患者报告结局测量信息系统(PROMIS)对类风湿关节炎的达标治疗(T2T)方法进行标准化和个性化:以患者为中心的治疗优先级的基线研究结果
Clin Rheumatol. 2017 Aug;36(8):1729-1736. doi: 10.1007/s10067-017-3731-5. Epub 2017 Jun 26.
2
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis.基于人群的类风湿关节炎欧洲队列患者中,疾病活动状态的类风湿关节炎疾病影响 (RAID) 评分和截断值定义的有效性。
Joint Bone Spine. 2018 May;85(3):317-322. doi: 10.1016/j.jbspin.2017.05.020. Epub 2017 May 24.
3
Patient-reported outcomes as predictors of remission in early rheumatoid arthritis patients treated with tight control treat-to-target approach.患者报告结局作为采用严格控制达标治疗方法治疗的早期类风湿关节炎患者缓解的预测指标。
Rheumatol Int. 2017 May;37(5):825-830. doi: 10.1007/s00296-017-3692-7. Epub 2017 Mar 13.
4
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.EULAR 推荐的类风湿关节炎治疗策略:2016 年更新版
Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6.
5
Development of a clinical decision support system for diabetes care: A pilot study.糖尿病护理临床决策支持系统的开发:一项试点研究。
PLoS One. 2017 Feb 24;12(2):e0173021. doi: 10.1371/journal.pone.0173021. eCollection 2017.
6
The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate Methotrexate.英格兰针对能够耐受甲氨蝶呤的类风湿关节炎患者的生物改善病情抗风湿药物治疗序列的成本效益
J Rheumatol. 2017 Jul;44(7):973-980. doi: 10.3899/jrheum.160941. Epub 2017 Feb 15.
7
Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools.通过对患者进行更严格的监测并使用创新电子工具来改善炎性关节炎的管理。
RMD Open. 2016 Nov 24;2(2):e000302. doi: 10.1136/rmdopen-2016-000302. eCollection 2016.
8
The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission.类风湿关节炎患者对疾病无活动状态的看法:一项旨在确定患者感知缓解关键领域的调查。
Ann Rheum Dis. 2017 May;76(5):855-861. doi: 10.1136/annrheumdis-2016-209835. Epub 2016 Nov 30.
9
Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature.类风湿关节炎疾病活动度测量中的患者整体评估:文献综述
Arthritis Res Ther. 2016 Oct 28;18(1):251. doi: 10.1186/s13075-016-1151-6.
10
The Computer Assisted Management in Early Rheumatoid Arthritis programme tool used in the CAMERA-I and CAMERA-II studies.用于CAMERA-I和CAMERA-II研究的早期类风湿性关节炎项目中的计算机辅助管理工具。
Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S69-S72. Epub 2016 Oct 18.

行动呼吁:如何改善患者报告结局的使用以指导类风湿关节炎的临床决策。

Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.

机构信息

Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Universités, UPMC Universitaire Paris 06, Paris, France.

Department of Rheumatology, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

出版信息

Rheumatol Int. 2018 Jun;38(6):935-947. doi: 10.1007/s00296-018-4005-5. Epub 2018 Mar 21.

DOI:10.1007/s00296-018-4005-5
PMID:29564549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5953992/
Abstract

Current guidelines for the management of rheumatoid arthritis (RA) recommend early treatment and a treat-to-target goal of remission or low disease activity. Over the past decade, this approach has been extremely successful in reducing disease activity and joint damage in patients with RA. At the same time, however, overall patient perception of well-being appears to have decreased with respect to outcome measures considered important by patients themselves, such as pain, fatigue, physical function and quality of life. The timely and effective use of patient-reported outcomes (PROs) could encourage physicians to focus more on the impact of RA on patients and how patients are feeling. This in turn would facilitate shared decision making between patients and physicians, ultimately leading to a more patient-centered approach and improved patient care. Indeed, PROs provide information about individual patients that complements information provided by physical assessment and composite scores, and can also be used to guide patient care, such as determining whether a clinic visit is needed or whether treatment modifications are necessary. This is particularly important for patients who do not achieve the aspirational target of remission or low disease activity with pharmacological treatment. A number of validated PRO questionnaires are available, but how and which PROs should be incorporated into rheumatology clinical practice as part of the decision-making process is still controversial. Combining PROs with technology, such as computer adaptive tests, electronic PRO systems, web-based platforms and patient dashboards, could further aid PRO integration into daily rheumatology clinical practice.

摘要

目前类风湿关节炎 (RA) 的管理指南建议早期治疗,并以缓解或低疾病活动度为治疗目标。在过去的十年中,这种方法在降低 RA 患者的疾病活动度和关节损伤方面取得了巨大成功。然而,与此同时,患者对自身重要的结局指标(如疼痛、疲劳、身体功能和生活质量)的整体幸福感似乎有所下降。及时有效地使用患者报告的结局 (PROs) 可以鼓励医生更加关注 RA 对患者的影响以及患者的感受。这反过来又可以促进医患之间的共同决策,最终实现更以患者为中心的方法和改善患者护理。事实上,PROs 提供了关于个体患者的信息,补充了体格检查和综合评分提供的信息,还可以用于指导患者护理,例如确定是否需要就诊或是否需要治疗调整。对于那些通过药物治疗无法达到缓解或低疾病活动度的理想目标的患者来说,这一点尤其重要。有许多经过验证的 PRO 问卷可用,但如何以及将哪些 PRO 纳入风湿病临床实践作为决策过程的一部分仍然存在争议。将 PRO 与技术(如计算机自适应测试、电子 PRO 系统、基于网络的平台和患者仪表板)相结合,可以进一步帮助将 PRO 整合到日常风湿病临床实践中。